Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
Jones, Espitia, Wang, Nawrocki, Carew (2019) Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies Cancer Commun (Lond) (IF: -1) 39(1) 72
Full text
Click the PDF icon to view the full text of the paper
Abstract
Links
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842502http://www.ncbi.nlm.nih.gov/pubmed/31706349
http://dx.doi.org/10.1186/s40880-019-0418-0
